Horizon Space Acquisition and ArcheNova Biotech Announce Definitive Merger Agreement

Key Facts

Horizon Space Acquisition and ArcheNova Biotech have announced a definitive merger agreement. Seeking Alpha reported that the business combination will result in the formation of ArcheNova Technology, which is intended to be listed on the Nasdaq stock exchange under the leadership of Dr. Jinli Zhou.

The merger aims to take ArcheNova Biotech public through a combination with the special purpose acquisition company (SPAC). The announcement represents a strategic liquidity event for the target company and establishes a direct path to the public equity markets.